Gilead, Arcus’ updated TIGIT data unlikely to resolve debates around space: #ASCO23 – Endpoints News June 3, 2023
AstraZeneca: Tagrisso-chemo combo improved progression-free survival in late-stage lung cancer trial – Endpoints News – Endpoints News May 17, 2023
FDA approves Otsuka and Lundbeck’s schizophrenia, bipolar disorder injection – Endpoints News – Endpoints News April 28, 2023
Ginkgo sells Zymergen lab to chemical and material manufacturer Solvay – Endpoints News April 4, 2023
89bio’s Phase 2b ENLIVEN Trial of Pegozafermin in Nonalcoholic Steatohepatitis (NASH) Achieved High Statistical Significance on Both Primary Histology Endpoints with Weekly (QW) and Every-Two-Week (Q2W) Dosing at 24 Weeks – Yahoo Finance March 22, 2023
What kind of PhIIb data is worth $4B cash? Takeda’s Andy Plump has some thoughts on that – Endpoints News March 17, 2023
Months after reorg, Adaptimmune merges with fellow cell therapy developer – Endpoints News March 6, 2023
The top 100 biotech VCs: Who’s staying at the table and what do they want now? – Endpoints News February 16, 2023